Ryabaya OO - Search Results

1

VEGF-R1 as a Potential Molecular Target for Anticancer Therapy.

Tyrsina EG, Nikulitskiy SI, Inshakov AN, Ryabaya OO. Tyrsina EG, et al. Among authors: ryabaya oo. Dokl Biochem Biophys. 2018 Jan;478(1):18-20. doi: 10.1134/S1607672918010052. Epub 2018 Mar 14. Dokl Biochem Biophys. 2018. PMID: 29536302

2

Detection and quantification of VEGFR-1 in the nuclei of tumor cells by a new flow cytometry-based method.

Tyrsina E, Nikulitskiy S, Inshakov A, Ryabaya O, Tyrsin D. Tyrsina E, et al. J Immunotoxicol. 2019 Dec;16(1):74-81. doi: 10.1080/1547691X.2019.1598522. J Immunotoxicol. 2019. PMID: 30985194

3

Autophagy inhibitors chloroquine and LY294002 enhance temozolomide cytotoxicity on cutaneous melanoma cell lines in vitro.

Ryabaya OO, Inshakov AN, Egorova AV, Emelyanova MA, Nasedkina TV, Zasedatelev AS, Khochenkov DA, Stepanova EV. Ryabaya OO, et al. Anticancer Drugs. 2017 Mar;28(3):307-315. doi: 10.1097/CAD.0000000000000463. Anticancer Drugs. 2017. PMID: 27941537

4

Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells.

Ryabaya O, Prokofieva A, Akasov R, Khochenkov D, Emelyanova M, Burov S, Markvicheva E, Inshakov A, Stepanova E. Ryabaya O, et al. Biomed Pharmacother. 2019 Jan;109:2548-2560. doi: 10.1016/j.biopha.2018.11.109. Epub 2018 Dec 5. Biomed Pharmacother. 2019. PMID: 30551515 Free article.

5

[Inactivation of Receptor Tyrosine Kinases Overcomes Resistance to Targeted B-RAF Inhibitors in Melanoma Cell Lines].

Ryabaya OO, Malysheva AA, Khochenkova YA, Solomko ES, Khochenkov DA. Ryabaya OO, et al. Mol Biol (Mosk). 2018 May-Jun;52(3):466-473. doi: 10.7868/S0026898418030096. Mol Biol (Mosk). 2018. PMID: 29989578 Free article. Russian.

6

In Vitro and In Vivo Electrochemical Measurement of Reactive Oxygen Species After Treatment with Anticancer Drugs.

Vaneev AN, Gorelkin PV, Garanina AS, Lopatukhina HV, Vodopyanov SS, Alova AV, Ryabaya OO, Akasov RA, Zhang Y, Novak P, Salikhov SV, Abakumov MA, Takahashi Y, Edwards CRW, Klyachko NL, Majouga AG, Korchev YE, Erofeev AS. Vaneev AN, et al. Among authors: ryabaya oo. Anal Chem. 2020 Jun 16;92(12):8010-8014. doi: 10.1021/acs.analchem.0c01256. Epub 2020 May 28. Anal Chem. 2020. PMID: 32441506

7

Antiangiogenic Activity of Alofanib, an Allosteric Inhibitor of Fibroblast Growth Factor Receptor 2.

Khochenkov DA, Solomko ES, Peretolchina NM, Ryabaya OO, Stepanova EV. Khochenkov DA, et al. Among authors: ryabaya oo. Bull Exp Biol Med. 2015 Nov;160(1):84-7. doi: 10.1007/s10517-015-3104-5. Epub 2015 Nov 24. Bull Exp Biol Med. 2015. PMID: 26597690

8

[Oncolytic Properties of a Mumps Virus Vaccine Strain in Human Melanoma Cell Lines].

Ammour YI, Ryabaya OO, Milovanova AV, Sidorov AV, Shohin IE, Zverev VV, Nasedkina TV. Ammour YI, et al. Among authors: ryabaya oo. Mol Biol (Mosk). 2018 Jul-Aug;52(4):659-666. doi: 10.1134/S002689841804002X. Mol Biol (Mosk). 2018. PMID: 30113031 Free article. Russian.

9

Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models.

Tsimafeyeu I, Ludes-Meyers J, Stepanova E, Daeyaert F, Khochenkov D, Joose JB, Solomko E, Van Akene K, Peretolchina N, Yin W, Ryabaya O, Byakhov M, Tjulandin S. Tsimafeyeu I, et al. Eur J Cancer. 2016 Jul;61:20-8. doi: 10.1016/j.ejca.2016.03.068. Epub 2016 Apr 29. Eur J Cancer. 2016. PMID: 27136102

10

Inhibition of endoplasmic reticulum stress-induced autophagy sensitizes melanoma cells to temozolomide treatment.

Ryabaya O, Prokofieva A, Khochenkov D, Abramov I, Zasedatelev A, Stepanova E. Ryabaya O, et al. Oncol Rep. 2018 Jul;40(1):385-394. doi: 10.3892/or.2018.6430. Epub 2018 May 9. Oncol Rep. 2018. PMID: 29749510

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page